KORU Medical forecasts FY2026 revenue of $47.5 million-$48.5 million
Reuters2026/08/11 15:58- KORU Medical guided FY 2026 revenue to USD 47.5-48.5 million, implying 15-18% year-on-year growth.
- Gross margin forecast at 62-64%.
- Outlook calls for positive adjusted EBITDA, cash balance above USD 7.5 million by year-end.
- FY 2025 revenue was USD 41.1 million; Q2 cash balance was USD 8.3 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Yelooo Integra Datanet corrects July securities holders registration report
Cakra Buana Resources Energi shareholder Republik Capital cuts stake to 9.3% from 11.3%
Preferred shares of South Korean companies are trading at a record 45% discount in ten years; Samsung's 110 trillion won buyback plan may help eliminate the "Korea discount"
Samsung Electronics' highly anticipated stock buyback plan is raising investor expectations that the South Korean giant will purchase non-voting preferred shares, narrowing their deep discount and setting a precedent for other companies.
Crypto prices
More
